Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Raymond H Mak, M.D.

Co-Author

This page shows the publications co-authored by Raymond Mak and Elizabeth Baldini.
Connection Strength

3.305
  1. Mean Heart Dose Is an Inadequate Surrogate for Left Anterior Descending Coronary Artery Dose and the Risk of Major Adverse Cardiac Events in Lung Cancer Radiation Therapy. Int J Radiat Oncol Biol Phys. 2021 08 01; 110(5):1473-1479.
    View in: PubMed
    Score: 0.231
  2. Association of Left Anterior Descending Coronary Artery Radiation Dose With Major Adverse Cardiac Events and Mortality in Patients With Non-Small Cell Lung Cancer. JAMA Oncol. 2021 02 01; 7(2):206-219.
    View in: PubMed
    Score: 0.230
  3. Statin Use, Heart Radiation Dose, and Survival in Locally Advanced Lung Cancer. Pract Radiat Oncol. 2021 Sep-Oct; 11(5):e459-e467.
    View in: PubMed
    Score: 0.229
  4. The impact of quantitative CT-based tumor volumetric features on the outcomes of patients with limited stage small cell lung cancer. Radiat Oncol. 2020 Jan 14; 15(1):14.
    View in: PubMed
    Score: 0.213
  5. EGFR mutant locally advanced non-small cell lung cancer is at increased risk of brain metastasis. Clin Transl Radiat Oncol. 2019 Sep; 18:32-38.
    View in: PubMed
    Score: 0.205
  6. Cardiac Radiation Dose, Cardiac Disease, and Mortality in Patients With Lung Cancer. J Am Coll Cardiol. 2019 06 18; 73(23):2976-2987.
    View in: PubMed
    Score: 0.205
  7. Outcomes by EGFR, KRAS, and ALK Genotype After Combined Modality Therapy for Locally Advanced Non-Small-Cell Lung Cancer. JCO Precis Oncol. 2018 Nov; 2:1-18.
    View in: PubMed
    Score: 0.196
  8. Clinical Outcomes After Lung Stereotactic Body Radiation Therapy in Patients With or Without a Prior Lung Resection. Am J Clin Oncol. 2018 07; 41(7):695-701.
    View in: PubMed
    Score: 0.192
  9. Radiation toxicity in patients with collagen vascular disease and intrathoracic malignancy treated with modern radiation techniques. Radiother Oncol. 2017 11; 125(2):301-309.
    View in: PubMed
    Score: 0.183
  10. Use of frailty to predict survival in elderly patients with early stage non-small-cell lung cancer treated with stereotactic body radiation therapy. J Geriatr Oncol. 2018 03; 9(2):130-137.
    View in: PubMed
    Score: 0.182
  11. Lymph node volume predicts survival but not nodal clearance in Stage IIIA-IIIB NSCLC. PLoS One. 2017; 12(4):e0174268.
    View in: PubMed
    Score: 0.177
  12. Radiologic-pathologic correlation of response to chemoradiation in resectable locally advanced NSCLC. Lung Cancer. 2016 12; 102:1-8.
    View in: PubMed
    Score: 0.170
  13. Inter-scan and inter-observer tumour volume delineation variability on cone beam computed tomography in patients treated with stereotactic body radiation therapy for early-stage non-small cell lung cancer. J Med Imaging Radiat Oncol. 2017 Feb; 61(1):93-98.
    View in: PubMed
    Score: 0.170
  14. Advanced nodal stage predicts venous thromboembolism in patients with locally advanced non-small cell lung cancer. Lung Cancer. 2016 06; 96:41-7.
    View in: PubMed
    Score: 0.164
  15. Updated patterns of failure after multimodality therapy for malignant pleural mesothelioma. J Thorac Cardiovasc Surg. 2015 May; 149(5):1374-81.
    View in: PubMed
    Score: 0.152
  16. Outcomes by tumor histology and KRAS mutation status after lung stereotactic body radiation therapy for early-stage non-small-cell lung cancer. Clin Lung Cancer. 2015 Jan; 16(1):24-32.
    View in: PubMed
    Score: 0.148
  17. Outcomes after combined modality therapy for EGFR-mutant and wild-type locally advanced NSCLC. Oncologist. 2011; 16(6):886-95.
    View in: PubMed
    Score: 0.117
  18. Aggressive therapy for patients with non-small cell lung carcinoma and synchronous brain-only oligometastatic disease is associated with long-term survival. Lung Cancer. 2014 Aug; 85(2):239-44.
    View in: PubMed
    Score: 0.036
  19. Definitive primary therapy in patients presenting with oligometastatic non-small cell lung cancer. Int J Radiat Oncol Biol Phys. 2014 Jul 15; 89(4):880-7.
    View in: PubMed
    Score: 0.036
  20. Low incidence of chest wall pain with a risk-adapted lung stereotactic body radiation therapy approach using three or five fractions based on chest wall dosimetry. PLoS One. 2014; 9(4):e94859.
    View in: PubMed
    Score: 0.036
  21. TU-E-BRB-02: A Decision Support Tool for SBRT Planning Using a Searchable DVH Database. Med Phys. 2012 Jun; 39(6Part24):3908.
    View in: PubMed
    Score: 0.031
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.